15829573

Source:http://linkedlifedata.com/resource/pubmed/id/15829573

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0021079, umls-concept:C0021080, umls-concept:C0030705, umls-concept:C0039194, umls-concept:C0205082, umls-concept:C0332281, umls-concept:C0332448, umls-concept:C0486616, umls-concept:C1274040, umls-concept:C1550315, umls-concept:C1831743
pubmed:issue	10
pubmed:dateCreated	2005-9-15
pubmed:abstractText	To determine clinical and immunological correlates of high dose chemotherapy (HDC) + autologous stem cell transplantation (ASCT) in patients with severe rheumatoid arthritis (RA), refractory to conventional treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-10555021, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-10555022, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-10723577, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-10922071, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11086103, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11160281, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11315914, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11592360, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11642497, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11920422, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-11953992, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-12121670, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-12384938, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-12393721, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-12905466, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-1433003, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-14994391, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-3257873, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-6409481, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-7552067, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-7575695, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-7575719, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-8441146, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-8478878, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-8546736, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-8846654, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-9251643, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-9566675, http://linkedlifedata.com/resource/pubmed/commentcorrection/15829573-9742987
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0003-4967
pubmed:author	pubmed-author:FliermanRR, pubmed-author:IsaacsJ DJD, pubmed-author:LevarhtE WEW, pubmed-author:PonchelFF, pubmed-author:ShubT ATA, pubmed-author:ToesR E MRE, pubmed-author:VerburgR JRJ, pubmed-author:WellingM MMM, pubmed-author:van DreunenLL, pubmed-author:van LaarJ MJM
pubmed:issnType	Print
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1397-405
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15829573-Adult, pubmed-meshheading:15829573-Antigens, CD, pubmed-meshheading:15829573-Antirheumatic Agents, pubmed-meshheading:15829573-Arthritis, Rheumatoid, pubmed-meshheading:15829573-C-Reactive Protein, pubmed-meshheading:15829573-Humans, pubmed-meshheading:15829573-Immunoglobulins, pubmed-meshheading:15829573-Immunophenotyping, pubmed-meshheading:15829573-Immunosuppression, pubmed-meshheading:15829573-Middle Aged, pubmed-meshheading:15829573-Peripheral Blood Stem Cell Transplantation, pubmed-meshheading:15829573-Severity of Illness Index, pubmed-meshheading:15829573-Synovial Membrane, pubmed-meshheading:15829573-T-Lymphocyte Subsets, pubmed-meshheading:15829573-Treatment Failure, pubmed-meshheading:15829573-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.
pubmed:affiliation	Department of Rheumatology, Division of Nuclear Medicine, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I